// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Current Smoking Status Increases the Risk of Axial Psoriatic Arthritis: An Explanation to Smoking Paradox

Dilek Solmaz - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Cyclophosphamide for the Treatment of Skin Fibrosis in Systemic Sclerosis: A Systematic Review

Marie Hudson - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Scleroderma

Cyclophosphamide

Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort

Sibel Zehra Aydin - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis

Armend Lokku - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Depression and Anxiety Symptoms in Childhood-Onset Systemic Lupus Erythematosus

Frank Silverio - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Lupus

N/A

Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity

Dorcas Beaton - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Description and Prevalence of Spondyloarthritis in Unselected Patients with Psoriasis, Acute Anterior Uveitis, and Inflammatory Bowel Disease Presenting with Undiagnosed Back Pain

Raj Carmona - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Inflammatory bowel disease

N/A

Descriptive Analysis of Biopsy-proven Antiphospholipid Antibody-associated Nephropathy Patients Included in the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registryâ€)

Medha Barbhaiya - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Designing and Testing Treat to Target as a New Care Model in JIA Across a Network of Pediatric Rheumatology Centers

Janalee Taylor - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Determinants of Cognitive Function in Rheumatoid Arthritis (RA) Patients

Linda Li - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Determining a Polygenic Risk Score in Pediatric Systemic Lupus Erythematosus

Michael Ombrello - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Developing a Comprehensive Patient-Specific Disease Progression Prediction Model for Knee Osteoarthritis Using Machine/Deep Learning Methods

Afshin Jamshidi - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Knee osteoarthritis

N/A

Development and Initial Validation of the MS Score for Diagnosis of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

Francesca Bovis - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Macrophage activation syndrome

N/A

Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease

Eiman Abd El-Latif - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Results

Stephane Zuily - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

N/A

Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia

Stephanie Chevalier - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

Differential Expression of Human Endogenous Retroviruses in Psoriatic Disease

Rohan Machhar - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Disease Activity in Childhood-Onset Systemic Lupus Erythematosus: Initial Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry

Mary Beth Son - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Lupus

N/A

Disease Activity Measures at Baseline and 3 Months as Predictors of Rapid Radiographic Progression in Methotrexate Naïve Patients with Early Rheumatoid Arthritis

Mohammad Movahedi - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Methotrexate

Distinct Characteristics of the Gut Microbiome of Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth

Giada De Palma - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Copyright © 2026. QuantiNova All rights reserved